BRCA2 mutation carriers, reproductive factors and breast cancer risk
- PMID: 12927042
- PMCID: PMC314423
- DOI: 10.1186/bcr619
BRCA2 mutation carriers, reproductive factors and breast cancer risk
Abstract
Background: Germline mutations in the BRCA genes dramatically increase the risk of breast cancer. In the general population, breast cancer risk is affected by age at menarche, by age at first birth, by the number of births and by the duration of breast feeding. Whether this is true for mutation carriers is not clear.
Methods: In a case-control study, nested in a population-based cohort of the Icelandic Cancer Detection Clinic, two groups of cases were defined, matched on year of birth, on age at diagnosis and on age when giving information on reproductive factors: 100 carriers of the Icelandic founder BRCA2 mutation 999del5, and 361 BRCA2-negative cases. The mean age at diagnosis was 48 years. There were 1000 women in a matched group of unaffected controls. Conditional logistic regression was used for the analysis.
Results: An increased number of births was associated with a decreased risk of breast cancer in BRCA2-negative cases but not in BRCA2-positive cases. A negative association between risk and duration of breast feeding was observed only in the mutation carriers. These associations were not statistically significant, but the effects of the two variables differed significantly according to mutation status (P = 0.007 and P = 0.045 for interaction with number of births and with duration of breast feeding, respectively). This was maintained when limiting the analysis to women diagnosed older than the age of 40 years.
Conclusion: The association between breast cancer and the number of pregnancies and between breast cancer and the duration of breast feeding was not the same for carriers and noncarriers of a detrimental BRCA2 mutation. In the context of other epidemiological and laboratory studies, this may indicate that the product of the BRCA2 gene has a function relating to the differentiation of epithelial tissue in the breast.
Similar articles
-
Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.J Natl Cancer Inst. 2006 Jan 18;98(2):116-22. doi: 10.1093/jnci/djj012. J Natl Cancer Inst. 2006. PMID: 16418514
-
Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3170-8. doi: 10.1158/1055-9965.EPI-08-0396. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18990759
-
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.J Natl Cancer Inst. 2004 Jul 21;96(14):1094-8. doi: 10.1093/jnci/djh211. J Natl Cancer Inst. 2004. PMID: 15265971
-
Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies.Cancer Epidemiol. 2014 Feb;38(1):1-8. doi: 10.1016/j.canep.2013.11.004. Epub 2013 Dec 12. Cancer Epidemiol. 2014. PMID: 24332935 Review.
-
Prognosis of BRCA-associated breast cancer: a summary of evidence.Breast Cancer Res Treat. 2010 Jan;119(1):13-24. doi: 10.1007/s10549-009-0566-z. Breast Cancer Res Treat. 2010. PMID: 19789974 Review.
Cited by
-
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers.Br J Cancer. 2016 Sep 27;115(7):776-83. doi: 10.1038/bjc.2016.249. Epub 2016 Aug 18. Br J Cancer. 2016. PMID: 27537391 Free PMC article.
-
Iceland-genetic counseling services.J Genet Couns. 2013 Dec;22(6):907-10. doi: 10.1007/s10897-013-9640-0. Epub 2013 Aug 15. J Genet Couns. 2013. PMID: 23949570
-
Pregnancy after breast cancer: latest evidence and practical considerations.Ther Adv Med Oncol. 2025 Jun 18;17:17588359251346648. doi: 10.1177/17588359251346648. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 40538639 Free PMC article. Review.
-
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.Breast Cancer Res Treat. 2010 Nov;124(2):441-51. doi: 10.1007/s10549-010-0842-y. Epub 2010 Mar 23. Breast Cancer Res Treat. 2010. PMID: 20309627 Free PMC article.
-
BRCA1/2 mutations, fertility and the grandmother effect.Proc Biol Sci. 2012 Aug 7;279(1740):2926-9. doi: 10.1098/rspb.2012.0542. Epub 2012 May 9. Proc Biol Sci. 2012. PMID: 22572204 Free PMC article. No abstract available.
References
-
- Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjord JE. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet. 1996;13:117–119. - PubMed
-
- Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G, Johannsson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V, Barkardottir RB. High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res. 1996;56:3663–3665. - PubMed
-
- Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE. Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet. 1998;352:1337–1339. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous